50 MINUTES ON HES - SPECIAL LECTURES, SPECIAL GUESTS

1. 1.Caminati M et al. Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC).. Cells. 2024 Jul 11;13(14):1180. doi: 10.3390/cells13141180. PMID: 39056762; PMCID: PMC11274683.. 2024
   Articolo scientificoCells. 2024 Jul 11;13(14):1180. doi: 10.3390/cells13141180. PMID: 39056762; PMCID: PMC11274683.Leggi il PDF gratuito
2. 2.Iurlo A et al. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?. Blood Rev. 2023 Mar;58:101014. doi: 10.1016/j.blre.2022.101014. Epub 2022 Sep 17. PMID: 36153195.. 2023
   Articolo scientificoBlood Rev. 2023 Mar;58:101014. doi: 10.1016/j.blre.2022.101014. Epub 2022 Sep 17. PMID: 36153195.Leggi il paperCerca versione gratuita
3. 3.Hoxha A et al. Hypereosinophilic Syndrome Following the BNT162b2 (BioNTech/Pfizer) Vaccine Successfully Treated with Mepolizumab: A Case Report and Review of the Literature.. J Clin Med. 2023 Mar 19;12(6):2376. doi: 10.3390/jcm12062376. PMID: 36983376; PMCID: PMC10051530.. 2023
   Articolo scientificoJ Clin Med. 2023 Mar 19;12(6):2376. doi: 10.3390/jcm12062376. PMID: 36983376; PMCID: PMC10051530.Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).